alphoid D1Z5 and the satellite II domains. The 1q breakpoint was within the pericentromeric region of chromosome 1, which is notoriously an unstable chromosomal region, involved in different chromosomal rearrangements.
der(1;14) in Myelodysplasia Cytogenet Genome Res 2012; 136:256-263 257 Michaux et al., 1996] . Very few data are available about der(1; 14), which is a much rarer chromosomal rearrangement [Busson-Le Coniat et al., 1999; Djordjević et al., 2005] . Here we report on the findings of fluorescence in situ hybridization (FISH) studies performed in a patient with MDS showing this unusual translocation.
Materials and Methods

Case Report
The patient is a 72-year-old female, diagnosed with bone marrow aplasia in 1996, at 56 years. After a treatment with antilymphocytic globulin, cyclosporin A and testosterone she achieved complete remission which lasted until March 2004, when she came to our attention because of pancytopenia, slight splenomegaly and low-grade fever. Blood counts showed: hemoglobin 7.6 g/l, white blood cells 1.5 ! 10 9 /l, platelets 110 ! 10 9 /l. Bone marrow was hypocellular and showed signs of dysplasia involving more than 10% of the myeloid, erythroid and megakaryocytic lineage. Therefore, the diagnosis was refractory cytopenia with multilineage dysplasia according to the WHO classification [Swerdlow et al., 2008] . The patient was offered a treatment with erythropoietin plus standard supportive measures. Follow-up bone marrow evaluations showed a substantially stable morphological picture. In 2006 she also developed a systemic sarcoidosis which was satisfactorily controlled by a high-dose steroid treatment. At present the patient's conditions are good, without signs of evolution to AML. The first cytogenetic analyses, performed at the time of the diagnosis of marrow aplasia and during the long-lasting stationary phase of the disease, showed normal karyotype, thus making more likely that the chromosomal change observed during the evolution to MDS is therapy-related.
Cytogenetic and FISH Studies
Standard procedures were used for routine cytogenetics. Metaphases obtained from unstimulated bone marrow cells were analyzed in GTG-or QFQ-banding after 24/48-hour culture.
FISH studies were performed using the following commercial probes: whole chromosome painting probes of chromosomes 1 and 14 (wcp1, wcp14), centromeric probes of chromosome 1 (locus D1Z5 and satellite II/III (SAT II/III)), all supplied by Abbott Molecular/Vysis (Des Plaines, Ill., USA) and Alphoid probe 14/22 (locus D14Z1/D22Z1), supplied by Cytocell Ltd (Cambridge, UK). The slides for FISH were prepared according to standard procedures and subsequently co-denatured together with the probes at 73 ° C for 2 min using the Vysis Hybrite Hybridization System (Downers Grove, Ill., USA). Afterwards, they were incubated overnight at 37-42 ° C and detected according to the suppliers' instructions. The slides were then stained with DAPI and observed with Olympus BX61 fluorescence microscope using suitable filters.
Results
Both analyses on bone marrow blood were performed in 1996, when the patient was diagnosed with bone marrow aplasia, and in 2004 during follow-up, normal karyotype in all the examined cells was shown.
The first analyses on bone marrow blood were performed in 1996, when the patient was diagnosed with bone marrow aplasia, and in 2004 during follow-up, and normal karyotype in all the examined cells was shown. These analyses were performed by another cytogenetic laboratory, and therefore data about the number of screened cells are unavailable. In 2005, the patient was admitted to the hematologic unit of our university. At that time, a standard cytogenetic analysis showed a mosaic of normal and pathological cells with a ratio of 14: 11 between normal and abnormal cells. In the pathological clone 1 chromosome 14 was replaced by a rearranged chromosome, seemingly consisting of the long arm of chromosome 1 and the long arm of chromosome 14 ( fig. 1 ). This interpretation was confirmed by FISH experiments with wcp probes of chromosomes 1 and 14 ( fig. 2 ) . The derivative chromosome, identified as der(1; 14), was positive for the alphoidspecific probe CEP(14/22) and negative for the alpha satellite probe of chromosome 1 (locus D1Z5) ( fig. 3 ) . The probe corresponding to the SAT II/III region of chromosome 1 gave a positive signal on der(1; 14) (not shown). These findings clearly indicated that the translocation breakpoint on chromosome 1 was located between the D1Z5 and SAT II/III locus, so sparing the centromeric alphoid block, while the chromosome 14 had a breakpoint on its short arm, retaining its own centromere. The complete karyotype of the abnormal clone, according to the International System for Human Cytogenetic Nomenclature [ISCN, 2009] (14) (red). The arrow indicates the der(1; 14). 
Discussion
Unbalanced WATs of chromosome 1q, which involve centromeric or pericentromeric regions of different chromosomes, differ from the typical balanced reciprocal translocations. In fact the abnormal clone retains 2 copies of an apparently normal chromosome 1 and only 1 out of the 2 possible derivatives, resulting in complete trisomy 1q, associated with partial monosomy of the partner chromosome. As reported in table 2 , the extra 1q may be fused with different recipient chromosomes, but some rearrangements, such as der(1; 7), der(1; 16) and der(1; 15), seem to recur in different hematological malignancies [Mitelman et al., 2011] . In particular, der(1; 7), which is the most frequent WAT of 1q, is non-randomly distributed among neoplastic hematological diseases, with a large prevalence in MDS/AML. The der(1; 16) is the second most frequent 1q WAT and is prevalent in MM. Other 1q rearrangements seem to be randomly shared among solid and hematological tumors, among which myeloid and lymphoid neoplasms are nearly equally involved. These differences could reflect the effects of the concomitant partial aneuploidy of the partner chromosome, which always occurs in this peculiar chromosomal rearrangement, namely monosomy 7q in der(1; 7) and monosomy 16p in der(1; 16). Another not less relevant aspect is that the derivative chromosome 1 is not often a single anomaly but is part of complex karyotypes.
The molecular mechanism of translocations involving the entire q arm of chromosome 1 has been exhaustively investigated by Alitalo et al. [1989] and Wang et al. [2003] on several patients with der(1; 7). These authors showed that the derivative chromosome contains 4 alphoid subsets, 2 from chromosome 1 and 2 from chromosome 7. They also demonstrated that the breakpoints on chromosome 1 are randomly distributed in different patients inside the alphoid block D1Z7. Therefore, the (1; 7) translocation indicated as der(1; 7)(q10;p10) or (q10;q10) gives rise to a dicentric chromosome. WATs of 1q to acrocentric chromosomes may be interesting to define the role of 1q trisomy in different tumors. In fact, only in cases where the recipient chromosome is an acrocentric and the 1q WAT is present as isolated karyotypic abnormality, the resulting chromosome imbalance may be considered as pure 1q trisomy. Indeed, the loss of the p arm of acrocentric chromosomes is irrelevant, similarly to what occurs in constitutional Robertsonian translocations, which do not seem to have phenotypic effect in normal carriers.
The most common WAT translocation involving an acrocentric chromosome is der(1; 15), reported in 33 hematologic patients with myeloid and lymphoid malignancies. FISH studies have been performed by Michaux et al. [1996] to investigate the role of centromeric sequences of both chromosomes in the origin of der(1; 15). Authors showed the dicentric nature of the der(1; 15) chromosome in 1 out of 3 patients reported and they suggested that the preservation of both centromeres could be a constant occurrence in translocation of 1q to chromosome 15.
The unbalanced translocation leading to der(1; 14) present in our patient is not a common chromosomal rearrangement. From Mitelman et al.
[2011] database we ALL = Acute lymphoblastic leukemia; AML = acute myeloid leukemia; CMML = chronic myelomonocytic leukemia; F = female; HL = Hodgkin lymphoma; LL = lymphoblastic lymphoma; M = male; MF = myelofibrosis; MDS = myelodysplastic syndrome; MM = multiple myeloma; MPD = myeloproliferative disease; NHL = nonHodgkin lymphoma; PV = polycythemia vera; PPMF = myelofibrosis after polycythemia vera; RAEB = refractory anemia with excess of blasts; RAEBt = refractory anemia with excess of blasts in transformation; RARS = refractory anemia with ringed sideroblasts; RCMD = refractory cytopenia with multilineage dysplasia.
have collected 23 cases of hematologic patients by using different searching criteria, i.e. karyotype formulae which have apparently the same meaning, such as 'der (14) t(1; 14)(q11;p11)', '+1,der(1; 14)', 'der(1; 14)(p10 or q10;p10 or q10)' or similar. Clinical and cytogenetic data of patients with der(1; 14), including ours, are reported in table 3 . Among these patients the male sex is prevalent (14: 10) and the median age at diagnosis, calculated on 21 patients (data were not available for 3 patients) is 59 years. Over 60% of patients (15/24) had a diagnosis of myeloid disorder, including AML, MDS and myeloproliferative disease, while the remaining patients had acute lymphoblastic leukemia/lymphoma or MM; 5 cases had polycythemia vera or myelofibrosis/MDS after polycythemia vera, in agreement with the high incidence of 1q trisomy already reported in these conditions [Swolin et al., 1986 [Swolin et al., , 2008 Andrieux et al., 2003] .
For most patients reported in table 2 , information about therapy and survival from diagnosis are incomplete, so that it is really hard to reach any firm conclusion about them.
All but 2 reported cases of der(1; 14) have been investigated by standard cytogenetic methods; FISH experiments with centromere-specific probes of chromosomes 1 and 14 are available for 2 patients [Busson-Le Coniat et al., 1999; Djordjević et al., 2005] . Busson-Le Coniat et al. [1999] reported FISH results of 1 patient with polycythemia vera and Djordjević et al. [2005] on 1 patient with chronic myelomonocytic leukemia. In the former, the der(1; 14) was negative for the chromosome 1-specific alpha satellite probe D1Z5, while it was positive for a chromosome 1-specific SAT II probe. According to FISH findings, the der(1; 14) was interpreted as a monocentric chromosome, with a unique centromere derived from chromosome 14. The breakpoint on 1q was located between the alphoid D1Z5 and the SAT II domain. In the latter case, the der(1; 14) was positive for a FISH probe specific for the secondary constriction of 1q (pUC1.77, 1q12-1q21), but no FISH results were available for the alpha satellite-specific probe.
In the present case, FISH findings show that the der(1; 14) has a unique centromere derived from chromosome 14, similarly to that observed by Busson-Le Coniat et al. [1999] in their patient. Future studies should further explore whether the mechanism shown as responsible for the occurrence of der(1; 14) in our patient is common in 1q WATs to chromosome 14.
Translocations with fusion of 2 chromosome arms, either of homologous or non-homologous chromosomes, produce a derivative chromosome often described as dicentric, although the translocation breakpoints are mostly unknown.
Most of these centromeric fusions involve chromosomes with large C bands, corresponding to large blocks of constitutive centromeric heterochromatin. They are variable in size in normal individuals, mainly at the centromeres of chromosomes 1, 9, and 16, and are known as common heteromorphisms. Centromeric translocations involving chromosome 1, which result in gain of 1q due to the persistence of 2 apparently normal chromosomes 1, may occur with different mechanisms: a primary duplication of a whole chromosome 1, which precedes the subsequent centromere translocation, or, alternatively, the centromere translocation could precede and perhaps predispose to a subsequent duplication of the entire chromosome 1 [Andersen and Pedersen-Bjergaard, 2000] . Another model suggests a simultaneous WAT and duplication of 1q, subsequent to heterochromatin decondensation, which seems to have a primary role in this rearrangement [Sawyer et al., 1998; Wong et al., 2001] .
Centromeric translocations typically do not involve key genes, whose disruption may account for neoplastic proliferation, as observed in several neoplasias, but they usually have as main consequence gain or loss of the entire whole arms of the involved chromosomes. Concerning the unbalanced t(1; 14) described in our patient, the main consequence is a genomic imbalance resulting from gain of the long arm of chromosome 1. Trisomies of entire arms are likely implicated in neoplastic processes by a gene dosage effect, analogous to what is reported for numerical aberrations, such as trisomy 8 or other full trisomies. The 1q trisomy implies a deregulation of several genes likely implicated in the control of normal cell cycle kinetics, with a consequent alteration of the balance between proliferation and cell death. Up-regulation of genes mapped to 1q has been shown by gene expression profiling analyses in MM patients with gain of 1q [Shaughnessy et al., 2006] , which suggests that gene deregulation could be the main mechanism of tumorigenesis in 1q rearrangements in these patients and likely in other tumors.
Therefore, other mechanisms could be implied, such as heterochromatin-dependent oncogenic mechanisms, as suggested by Fournier et al. [2007] . Constitutive heterochromatin is a specialized compartment within the chromatin and is found primarily at centromeres, telomeres and the pericentromeric regions of certain chromosomes, including chromosome 1. It is composed of gene-poor, repetitive DNA sequences (alpha satellite, SAT II, III) with a pre-eminent role in the control of genome stability, but it is also relevant for epigenetic control of gene expression through a process termed gene silencing. The involvement of 1q12 SAT II-rich constitutive heterochromatin in several 1q rearrangements suggests that this chromosomal region is absolutely important for initiating and/or progression of different tumors. Our case highlights that FISH studies with appropriate probes of chromosomal rearrangements involving 1q heterochromatin could be helpful to improve our knowledge about this portion of the human genome, mainly concerning its possible role in the pathogenesis of neoplastic disorders.
